BMC Cancer volume 18, Article number: 110 (2018)
The Original Article was published on 16 August 2017
After publication of the original article [1] the authors found that Table 2 had been formatted incorrectly, meaning that some rows in the Table did not display the correct information.
An updated version of Table 2 is included with this Correction.
The original article has also been updated.
Lange M, Laviec H, Castel H, Heutte N, Leconte A, Léger I, Giffard B, Capel A, Dubois M, Clarisse B, Coquan E, Di Fiore F, Gouérant S, Bartélémy P, Pierard L, Karim F, Joly F. Impact of new generation hormone-therapy on cognitive function in elderly patients treated for a metastatic prostate cancer: Cog-Pro trial protocol. BMC Cancer. 2017;17:549. https://doi.org/10.1186/s12885-017-3534-8.
The online version of the original article can be found under https://doi.org/10.1186/s12885-017-3764-9
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Lange, M., Laviec, H., Castel, H. et al. Correction to: Impact of new generation hormone-therapy on cognitive function in elderly patients treated for a metastatic prostate cancer: Cog-Pro trial protocol. BMC Cancer 18, 110 (2018). https://doi.org/10.1186/s12885-017-3764-9
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s12885-017-3764-9
